Sentences with phrase «advanced lung cancer»
The medicines, which help unleash the immune system on cancer cells, were tested in patients with advanced lung cancer.
cnbc.com
In two advanced lung cancer trials, which we covered, new drugs targeting familiar faulty molecules showed promise.
The trial involved nine men with advanced lung cancer.
«What is particularly encouraging is that we are now able to select, based on features in the tumor, approximately a quarter of advanced lung cancer patients who can receive immunotherapy as their initial treatment.
Dyadic psychosocial intervention for advanced lung cancer patients and their family caregivers: Results of a randomized pilot trial
In addition, the study showed that the 5 - year survival rate for selected older patients with advanced lung cancer who were treated with surgical therapy was 29.9 % for Stage III and 26.7 % for Stage IV.
Previous study of ours showed that advanced lung cancer inflammation index (ALI) and C - reactive protein (CRP) are independent significant prognostic factors in operable non-small cell lung cancer (NSCLC) patients.
Merck's cancer immunotherapy Keytruda is one of the pharma giant's rising stars, especially in the wake of evidence that the therapy had a survival benefit over standard chemotherapy in advanced lung cancer patients.
That's not just because of Opdivo's failure — last month, Keytruda was shown to be better than standard chemotherapy in untreated advanced lung cancer patients with high levels of the PD - L1 protein, both stopping cancer progression and extending patients» lives.
10/7/2008 Novel Lung Cancer Vaccine Trial Launched at Moores UCSD Cancer Center Oncologists at the Moores Cancer Center at the University of California, San Diego (UCSD) in La Jolla are hoping to stave off the relentless march of advanced lung cancer by treating patients with a novel kind of cancer vaccine.
IMRT is already being used as a safer and more effective alternative to other cancers such as brain and prostate cancer, but Chun's study was the first analysis of a trial that showed reduced radiation therapy related toxicity in patients with locally advanced lung cancer through the use of IMRT.
The early and promising results could actually give the firm an advantage over rivals like Roche and Merck, the latter of which scored an important FDA approval for its immunotherapy drug Keytruda in combination with chemotherapy for advanced lung cancer this week.
«Breakthrough drug approved as alternative to chemotherapy for people with advanced lung cancer.»
This drug will be used for patients with metastatic or advanced lung cancer who did not respond to previous treatments.
Aria Stone is currently raising funds to help her partner, Tony Dibley, who is dealing with an illness of advanced lung cancer.
Without immunotherapy, the five year survival rate is only one percent in a study of 129 patients with advanced lung cancer.
In a study of 50 people with advanced lung cancer, those judged to have high «spiritual faith» responded better to chemotherapy and survived longer
«Pembrolizumab new option for first line treatment of patients with advanced lung cancer and high PD - L1 expression.»
«Chemotherapy may be better for certain patients with advanced lung cancer.»
Pembrolizumab is set to become a new option for first line treatment of patients with advanced lung cancer and high PD - L1 expression, according to the results of the phase III KEYNOTE - 024 trial presented at the ESMO 2016 Congress in Copenhagen and published in the New England Journal of Medicine.
When doctors examined Shibendra Das in 2013, they thought he had advanced lung cancer.
«Rapid advancements in genetic testing offer new treatment options for patients with advanced lung cancer.
Geneva, Switzerland, 05 May 2017 — Osimertinib improves cancer - related symptoms in patients with advanced lung cancer, according to an analysis of patient - reported outcomes from the AURA3 phase III clinical trial presented today at the European Lung Cancer Conference.
Combination of Advanced Lung Cancer Inflammation Index and C - Reactive Protein Is a Prognostic Factor in Patients With Operable Non-Small Cell Lung Cancer Previous study of ours showed that advanced lung cancer inflammation index (ALI) and C - reactive protein (CRP) are independent significant prognostic factors in operable non-small cell lung cancer (NSCLC) patients.
Merck's Keytruda showed promise in its latest trial in prolonging survival rates among patients with advanced lung cancer.
Keytruda showed promise in its latest clinical trial as the better treatment for advanced lung cancer.